// App-Quantinova.ai

: Proteomic Pathways Across Ejection Fraction Categories in Heart Failure An Exscel Substudy

Researchers

Presenter

  • Anthony E Peters

Principal Investigators

  • Maggie Nguyen

  • Jennifer Green

  • Ewan Pearson

  • John Buse

  • Harald Sourij

  • Adrian F Hernandez

  • Naveed Sattar

  • Rury Holman

  • Robert J Mentz

  • Svati H Shah

Medical Centers

  • Duke Molecular Physiology Institute, Durham, NC

  • University of North Carolina, Chapel Hill, NC

  • Univ of Dundee

  • UNIVERSITY OF GLASGOW, Glasgow

  • Med Univ of Graz, Graz

  • Duke Clinical Research Institute, Durham, NC

  • DUKE UNIV MEDICAL CENTER, Hillsborough, NC

  • Duke Hosp, Durham, NC

  • Univ of Oxford, Oxford

Locations

  • United States

  • United Kingdom

  • South Africa

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

  • Congestive heart failure

  • Diabetes

  • Heart failure with mid-range Ejection Fraction

  • Heart failure with preserved ejection fraction

  • Heart failure with reduced ejection fraction

Biomarkers

  • N/A

Drug/Treatment

  • Exenatide

  • EF-40

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved